Evidence map›Paper›PMID 23801258›Full record

ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2013

Prion-like propagation of protein aggregation and related therapeutic strategies.

Sarah K Kaufman, Marc I Diamond

Open access · bronzeAbstract readReview
In one paragraph

Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.Frontiers in molecular neuroscience · 2019
    Review
  10. Prion-Like Mechanisms in Parkinson's Disease.Frontiers in neuroscience · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sarah K KaufmanDepartment of Neurology, Washington University in St Louis, 660 South Euclid Avenue, St Louis, MO 63110, USA.
Marc I Diamond
Washington University in St. Louis · US

Funding

CELL-CELL TRANSFER AND PROPAGATION OF TAU AGGREGATESR01NS071835 · NINDS · WASHINGTON UNIVERSITY · PI DIAMOND, MARC I · 2010 to 2014
$1.6M
NINDS NIH HHS R01 NS071835
6 · The paper itself

Abstract

Many neurodegenerative diseases are characterized by the progressive accumulation of aggregated protein. Recent evidence suggests the prion-like propagation of protein misfolding underlies the spread of pathology observed in these diseases. This review traces our understanding of the mechanisms that underlie this phenomenon and discusses related therapeutic strategies that derive from it.

Indexed as

alpha-SynucleinAmyloid beta-PeptidesAnimalsBrainHumansNeurodegenerative DiseasesNeuronsPrionsProtein Conformationalpha-SynucleinAmyloid beta-PeptidesPrions

Identifiers

PMID23801258
PMCPMC3701767
OpenAlexW2089729956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.